Cardinal Health Stock Price, News & Analysis (NYSE:CAH)

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Thursday, May 9th. Investors of record on Monday, July 1st will be paid a dividend of $0.4811 per share on Monday, July 15th. This represents a $1.92 annualized dividend and a yield of 4.02%. The ex-dividend date of this dividend is Friday, June 28th. This is an increase from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's Dividend History.

Cardinal Health announced that its board has initiated a stock buyback program on Thursday, November 8th 2018, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's leadership believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) posted its quarterly earnings results on Thursday, August, 8th. The company reported $1.11 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.93 by $0.18. The business had revenue of $37.35 billion for the quarter, compared to the consensus estimate of $36.70 billion. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. Cardinal Health's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.01 EPS. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Cardinal Health.

Cardinal Health issued an update on its FY20 earnings guidance on Thursday, August, 8th. The company provided earnings per share guidance of $4.85 to $5.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.10.

9 Wall Street analysts have issued 1-year target prices for Cardinal Health's shares. Their forecasts range from $41.00 to $61.00. On average, they expect Cardinal Health's stock price to reach $52.8571 in the next twelve months. This suggests a possible upside of 10.4% from the stock's current price. View Analyst Price Targets for Cardinal Health.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

News headlines about CAH stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cardinal Health earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Aceto (ACET).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Becton Dickinson and (BDX), General Electric (GE), Gilead Sciences (GILD), Verizon Communications (VZ) and Pfizer (PFE).

Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.01%), BlackRock Inc. (7.27%), BlackRock Inc. (7.27%), Bank of New York Mellon Corp (2.76%), Invesco Ltd. (2.73%) and American International Group Inc. (2.35%). Company insiders that own Cardinal Health stock include Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Barrow Hanley Mewhinney & Strauss LLC, Barrow Hanley Mewhinney & Strauss LLC, BlackRock Inc., BlackRock Inc., Morgan Stanley, Van ECK Associates Corp and American International Group Inc.. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Swedbank, Invesco Ltd., Nuveen Asset Management LLC, Vanguard Group Inc., Pzena Investment Management LLC, Royal Bank of Canada, AXA and Canada Pension Plan Investment Board. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $47.89.

Cardinal Health has a market capitalization of $14.28 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe.View Additional Information About Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]